Cambridge Investment Research Advisors’s FT Vest U.S. Equity Max Buffer ETF - August AUGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Sell
9,138
-15
-0.2% -$521 ﹤0.01% 3393
2026
Q1
$310K Sell
9,153
-642
-7% -$21.9K ﹤0.01% 3255
2025
Q4
$333K Sell
9,795
-51
-0.5% -$1.72K ﹤0.01% 3096
2025
Q3
$331K Buy
9,846
+2,138
+28% +$71.2K ﹤0.01% 3033
2025
Q2
$253K Sell
7,708
-650
-8% -$20.8K ﹤0.01% 3127
2025
Q1
$265K Sell
8,358
-568
-6% -$18.2K ﹤0.01% 2977
2024
Q4
$284K Sell
8,926
-348
-4% -$11.1K ﹤0.01% 2879
2024
Q3
$293K Buy
+9,274
New +$291K ﹤0.01% 2852

Other funds holding AUGM

Cambridge Investment Research Advisors's AUGM Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its FT Vest U.S. Equity Max Buffer ETF - August (AUGM) stake by 0.16% in Q2 2026, selling an estimated $521 and leaving 9,138 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Cambridge Investment Research Advisors first reported a position in AUGM in Q3 2024 and has held it in 8 quarters since. The position peaked at $333K in Q4 2025. 40 funds tracked by Wall St. Rank hold AUGM as of Q2 2026.

  • Cambridge Investment Research Advisors held 9,138 shares of FT Vest U.S. Equity Max Buffer ETF - August worth $320K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 15 FT Vest U.S. Equity Max Buffer ETF - August shares in Q2 2026, an estimated $521.
  • FT Vest U.S. Equity Max Buffer ETF - August made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3393 holding.
  • Cambridge Investment Research Advisors first reported a position in FT Vest U.S. Equity Max Buffer ETF - August in Q3 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's FT Vest U.S. Equity Max Buffer ETF - August position peaked at $333K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - August as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.